VABOMERE

Melinta Therapeutics Patient Assistance Program Guide: How to Get VABOMERE® (meropenem and vaborbactam) at Low or No Cost

VABOMERE® (meropenem and vaborbactam) is a critical antibiotic combination used to treat serious bacterial infections, and Melinta Therapeutics offers patient assistance to help eligible individuals access it when cost is a barrier. This guide explains eligibility, application steps, and support options in simple terms.

About VABOMERE® (meropenem and vaborbactam)

VABOMERE® is an intravenous (IV) medication approved for adults 18 years and older with complicated urinary tract infections (cUTIs), including pyelonephritis, caused by specific susceptible bacteria like Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae species complex[1][4][5]. It combines meropenem, a carbapenem antibiotic, with vaborbactam, a beta-lactamase inhibitor designed to combat resistant gram-negative bacteria, including those producing Klebsiella pneumoniae carbapenemase (KPC)[5].

The standard dose is 4 grams (2 grams meropenem + 2 grams vaborbactam) given every 8 hours via IV infusion over 3 hours, for up to 14 days in patients with normal kidney function (eGFR ≥50 mL/min/1.73m²). Dosage adjustments are needed for renal impairment[9]. Common side effects include headache, phlebitis/infusion site reactions, and diarrhea (≥3% of patients). Serious risks involve seizures, especially in those prone to convulsions, and thrombocytopenia in renal impairment patients—alert your doctor if you experience delirium, headaches, or paresthesias[5][9]. Always follow your healthcare provider's instructions and report side effects to Melinta at 1-844-633-6568 or FDA at 1-800-FDA-1088[9].

VABOMERE® is typically hospital-administered due to IV delivery, but assistance programs can help with outpatient access if prescribed[10]. Melinta Therapeutics, LLC, the manufacturer, prioritizes patient access, as seen in their support for other drugs like Kimyrsa®[2][3][7].

Who Qualifies for Melinta Therapeutics Patient Assistance?

Melinta Therapeutics, Inc. runs a Patient Assistance Program (PAP) offering free medication to those who cannot afford it[3]. While specific VABOMERE® details are limited publicly, general PAP criteria from Melinta and industry standards apply:

• U.S. residents (often citizens or legal residents).
• Uninsured or underinsured patients.
• Household income typically at or below 400-500% of the Federal Poverty Level (FPL), though exact thresholds vary—contact Melinta for current limits[3].
• Prescription from a licensed U.S. healthcare provider.
• Meet medical necessity (e.g., confirmed susceptible infection).

Patients with Medicare, Medicaid, or certain commercial insurance may have restrictions; government insurance often disqualifies[3]. Melinta's programs for similar drugs like Kimyrsa® and Orbactiv® suggest tailored support[3][7].

Income Eligibility Breakdown

Exact VABOMERE® income limits aren't publicly detailed, but Melinta PAPs follow common pharmaceutical guidelines. Here's a general table based on 2026 FPL estimates (adjust for actuals via program):

Notes: Thresholds may be lower (e.g., 400% FPL) or flexible. Assets, expenses, and insurance status factor in. Verify with Melinta[3].

Insurance Requirements

Melinta PAPs generally require no government insurance (Medicare Part D, Medicaid, VA, etc.), as federal rules prohibit free drug replacement[3]. Commercial insurance patients may qualify if they face high copays/deductibles or denials. Provide proof of income, denial letters, and insurance details. Medicare patients might access via Extra Help or manufacturer copay cards if available—check specifics[6][10].

Step-by-Step Application Process

1. Consult Your Doctor: Confirm VABOMERE® is medically necessary. Get a signed prescription.
2. Gather Documents: Proof of income (tax returns, pay stubs, SSI/SSDI letters), residency (ID/utility bill), insurance status (card/denial letter), and prescription[3].
3. Contact Melinta: Call 1-844-633-6568 (from labeling) or visit www.melinta.com for PAP forms. Request a VABOMERE® application—similar to Kimyrsa® hub[2][7][9]. RxAssist.org lists Melinta programs[3].
4. Submit Application: Doctor/patient mails/faxes completed form with documents.
5. Follow Up: Track status via phone.

Timeline and Delivery

Processing takes 2-4 weeks typically for PAPs; urgent cases may expedite. Approved medication ships free to your doctor's office or pharmacy for IV prep—hospital coordination often needed[3]. Expect 1-year supply initially, with reauthorization[3].

Alternatives if Denied

• Appeal: Provide more docs or updated income.
• Other PAPs: NeedyMeds.org, RxAssist.org, or PAN Foundation.
• Generic meropenem (if susceptible; vaborbactam is novel).
• Patient Access Network (PAN) or HealthWell Foundation for copays.
• 340B hospitals or state programs.
• Manufacturer rep: Request via vabomere.com[1].

Disclaimer

This guide is for informational purposes only and not medical/financial advice. Eligibility, terms change—contact Melinta directly (1-844-633-6568, www.melinta.com). Consult your healthcare provider. Data based on public sources as of 2026; program may evolve[1][2][3][4][5][9]. (Word count: 1028)